(4-Butoxy-2,3-difluorophenyl)boronic acid | CAS:156487-12-6

We serve (4-Butoxy-2,3-difluorophenyl)boronic acid CAS:156487-12-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
(4-Butoxy-2,3-difluorophenyl)boronic acid

Product Name: (4-Butoxy-2,3-difluorophenyl)boronic acid
Other Name: (4-Butoxy-2,3-difluorophenyl)boronic acid
CAS No: 156487-12-6
MF: C10H13BF2O3
MW: 230.01600
Density: 1.2±0.1 g/cm3
Boiling point: 341.7±52.0 °C at 760 mmHg
Melting point: N/A
Flash point: 160.4±30.7 °C
Refractive index: 1.483
UN Number: UN3261
Transport hazard class: 8
Packing group: III
 
Specification
Appearance: White powder
Assay: ≥98.0%
Water: ≤0.50%
 
Application
Be used as pharmaceutical intermediate, OLED intermediate.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.



Contact us for information like (4-Butoxy-2,3-difluorophenyl)boronic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,(4-Butoxy-2,3-difluorophenyl)boronic acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,(4-Butoxy-2,3-difluorophenyl)boronic acid Use and application,(4-Butoxy-2,3-difluorophenyl)boronic acid technical grade,usp/ep/jp grade.


Related News: According to statistics, in 2017, China’s total production of chemical drugs reached 3.478 million tons, a year-on-year increase of 1.6%. The main business income showed a steady increase, from 328.972 billion yuan in 2012 to 573.475 billion yuan in 2017. The total profit was 48.644 billion yuan, but profit margins remain low (8.48% in 2017).4-(3-Methylphenyl)Amino-3-Pyridinesulfonamide manufacturer Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday.3-BROMOPENTANE supplier Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday.4'-(Trifluoromethyl)acetophenone vendor Most foreign drugmakers offered Beijing the lowest prices globally in a recent round of negotiations in order to get some of their new products included in national insurance program, a move that will help them gain access to more patients in less-affluent cities, officials said on Thursday.As United Airlines said when suspended flights to Beijing, Shanghai and Chengdu, the decision was made “due to the continued drop in demand for travel to China and the US Department of State’s decision to raise its China travel advisory to a Level 4.”